10-K: Ultralife Corporation Reports FY 2024 Results, Driven by Battery & Energy Products Growth
Annual Report
Ultralife Corporation's FY 2024 results show revenue growth driven by the Battery & Energy Products segment, offset by a decline in Communications Systems sales.
Summary
- Ultralife Corporation reported a 3.7% increase in revenue for FY 2024, reaching $164.46 million compared to $158.64 million in FY 2023.
- The Battery & Energy Products segment saw a 10.9% revenue increase, while the Communications Systems segment experienced a 29.0% decrease.
- Gross margin improved to 25.7% from 24.7% due to better price alignment and operational efficiencies.
- Operating expenses increased by 8.8% to $32.35 million, primarily due to acquisition-related costs and investments in new product development.
- Net income attributable to Ultralife Corporation was $6.31 million, or $0.38 per share, compared to $7.20 million, or $0.44 per share, in the previous year.
- Adjusted EBITDA increased to $16.48 million from $15.70 million in the prior year.
- The company's backlog and high confidence orders stood at $102.16 million at the end of 2024.
- The acquisition of Electrochem Solutions, Inc. contributed $6.06 million in revenue after October 31, 2024.
Sentiment
Score: 6
Explanation: The document presents a mixed picture. While revenue and adjusted EBITDA increased, net income decreased and a material weakness in internal controls was identified. The outlook is positive, but risks remain.
Positives
- Revenue increased by 3.7% to $164.46 million.
- Battery & Energy Products segment revenues increased by 10.9%.
- Gross margin improved to 25.7% from 24.7% due to better price alignment and operational efficiencies.
- Adjusted EBITDA increased to $16.48 million from $15.70 million in the prior year.
- The company's backlog and high confidence orders stood at $102.16 million at the end of 2024, indicating strong future demand.
- Electrochem acquisition contributed $6.06 million in revenue after October 31, 2024, expanding the company's market reach.
Negatives
- Communications Systems segment revenues decreased by 29.0%.
- Operating expenses increased by 8.8% to $32.35 million, primarily due to acquisition-related costs.
- Net income attributable to Ultralife Corporation decreased to $6.31 million, or $0.38 per share, from $7.20 million, or $0.44 per share, in the previous year.
Risks
- The company is dependent on sales to U.S. Government customers.
- Supply chain disruptions and increased lead times for certain components could impact the ability to meet contractual timelines.
- Fluctuations in the demand, supply and price of oil and gas and the resulting volatility in the level of downhole drilling could have a material adverse effect on our business, financial condition and results of operations.
- The company is subject to certain safety risks, including the risk of fire or explosion, inherent in the manufacture, use and transportation of Lithium batteries.
- The company is subject to foreign currency fluctuations.
- The company identified a material weakness in its internal control over financial reporting.
Future Outlook
The company expects to deliver profitable growth and incremental cash flow to reduce debt and support strategic capital expenditures, driven by a broadened opportunity set in high-growth end markets, the integration of Electrochem, new product launches, and a strengthened sales and marketing leadership team.
Industry Context
The company operates in the battery and communications systems markets, which are characterized by intense competition from both development stage companies and major domestic and international players. The company competes on the basis of design flexibility, performance, price, reliability, and customer support.
Stakeholder Impact
- Shareholders may be concerned about the decrease in net income and the identified material weakness in internal controls.
- Employees may be affected by the ongoing integration of Electrochem and the efforts to remediate the material weakness.
- Customers may benefit from the expanded product offerings and improved efficiencies resulting from the Electrochem acquisition.
- Suppliers may be impacted by the company's efforts to optimize its supply chain and realize cost synergies.
Next Steps
- Complete the integration of Electrochem and realize manufacturing cost efficiencies and U.S.-based vertical integration savings.
- Launch new products.
- Strengthen the sales and marketing leadership team to expedite organic growth and further leverage our global brand and resources.
- Remediate the identified material weakness in internal control over financial reporting by hiring additional accounting personnel.
Key Dates
| Date | Description |
|---|---|
| 1990-12 | Ultralife was formed as a Delaware corporation. |
| 1991-03 | Acquired certain technology and assets from Eastman Kodak Company relating to its 9volt Lithium Manganese Dioxide non-rechargeable battery. |
| 1992-12 | Completed initial public offering and became listed on NASDAQ. |
| 2006-05 | Acquired ABLE New Energy Co., Ltd. |
| 2006-07 | Acquired substantially all the assets of McDowell Research, Ltd. |
| 2008-03 | Formed a joint venture, named Ultralife Batteries India Private Limited (India JV), with our distributor partner in India. |
| 2009-03 | Acquired the tactical communications products business of Science Applications International Corporation. |
| 2016-01 | Acquired Accutronics Limited. |
| 2019-05-01 | Acquired Southwest Electronic Energy Corporation. |
| 2021-12-13 | Acquired Excell Battery Canada Inc. and Excell Battery Corporation USA. |
| 2024-06-30 | Aggregate market value of the common stock held by non-affiliates was approximately $107,463,992. |
| 2024-07-16 | Stockholders approved the 2024 Long-Term Incentive Plan. |
| 2024-10-01 | The Company conducted its annual impairment test for goodwill and other indefinite-lived intangible assets. |
| 2024-10-31 | Acquired Electrochem Solutions, Inc. |
| 2025-03-01 | There were approximately 5,700 registered holders of record of our common stock. |
| 2025-03-28 | The registrant had 16,632,965 shares of common stock outstanding. |
Keywords
Ultralife Corporation, financial results, Battery & Energy Products, Communications Systems, revenue, gross margin, net income, EBITDA, Electrochem, acquisition, backlog, Lithium batteries, defense, military, commercial
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.